Svas Biosana S.p.A. (BIT:SVS)

Market Cap	48.78M +10.6%
Revenue (ttm)	141.56M +15.8%
Net Income	6.77M +15.2%
EPS	1.29 +17.3%
Shares Out	5.22M
PE Ratio	7.22
Forward PE	7.35
Dividend	0.25 (2.68%)
Ex-Dividend Date	Jun 1, 2026

Volume	n/a
Open	9.50
Previous Close	9.34
Day's Range	9.22 - 9.50
52-Week Range	7.42 - 10.80
Beta	0.95
Analysts	Strong Buy
Price Target	12.00 (+30.15%)
Earnings Date	Jun 26, 2026

About Svas Biosana

SVAS Biosana S.p.A. engages in the production and marketing of medical devices worldwide. The company offers incontinence aids, traditional dressings, and personal care products for use in incontinence devices, dressings, and personal care product applications. It also offers operating packs, medical devices, infusion and aspiration, linen, advanced dressings, and lubricating gels that are used in haemodynamic, heart surgery, anaesthesia, and critical care applications. In addition, the company provides specialist medical devices for use in onc...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1972
• Employees: 348
• Stock Exchange: Borsa Italiana
• Ticker Symbol: SVS

Financial Performance

In 2025, Svas Biosana's revenue was 141.56 million, an increase of 15.76% compared to the previous year's 122.29 million. Earnings were 6.77 million, an increase of 15.24%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jun 17, 2026

Data Sources Report a data error